BACKGROUND: Pulmonary rehabilitation (PR) is beneficial for some, but not all, patients with chronic lung disease. OBJECTIVES: To determine the success rate of a comprehensive PR program for patients with chronic obstructive pulmonary disease (COPD) and to characterize the differences between responders and nonresponders. METHODS: A chart review was performed on patients with a clinical diagnosis of COPD who were referred for PR. Success was defined according to clinically important changes in St George's Respiratory Questionnaire scores and⁄or 6 min walk test distance. RESULTS: The majority of subjects were men (58%) with a mean (± SD) age of 69±10 years (n=177). Sixty-two per cent of participants had a successful outcome with PR, with proportionally more responders noting subjective improvement than objective improvement on a 6 min walk test (73% versus 51%). Subjects with poor baseline St George's Respiratory Questionnaire scores tended to improve the most (P=0.011 [ANOVA]). Successful participants had a greater forced expired volume in 1 s (1.1 L versus 0.9 L; P<0.05) and a lower BODE index (body mass index, airflow obstruction, dyspnea, and exercise capacity index) at baseline (9.6 versus 10.3; P<0.05). Success of PR was not correlated with age, sex, chronic hypoxemic respiratory failure or other chronic conditions. Successful participants were more likely to be compliant and to experience fewer adverse events (P≤0.001). CONCLUSIONS: Our study reinforced the belief that the majority of participants with COPD benefit from PR. Few baseline characteristics were predictive of success. Subjectively measured improvement occurred more frequently than objectively measured improvement and was greatest in those with the poorest baseline values.
BACKGROUND: Pulmonary rehabilitation (PR) is beneficial for some, but not all, patients with chronic lung disease. OBJECTIVES: To determine the success rate of a comprehensive PR program for patients with chronic obstructive pulmonary disease (COPD) and to characterize the differences between responders and nonresponders. METHODS: A chart review was performed on patients with a clinical diagnosis of COPD who were referred for PR. Success was defined according to clinically important changes in St George's Respiratory Questionnaire scores and⁄or 6 min walk test distance. RESULTS: The majority of subjects were men (58%) with a mean (± SD) age of 69±10 years (n=177). Sixty-two per cent of participants had a successful outcome with PR, with proportionally more responders noting subjective improvement than objective improvement on a 6 min walk test (73% versus 51%). Subjects with poor baseline St George's Respiratory Questionnaire scores tended to improve the most (P=0.011 [ANOVA]). Successful participants had a greater forced expired volume in 1 s (1.1 L versus 0.9 L; P<0.05) and a lower BODE index (body mass index, airflow obstruction, dyspnea, and exercise capacity index) at baseline (9.6 versus 10.3; P<0.05). Success of PR was not correlated with age, sex, chronic hypoxemic respiratory failure or other chronic conditions. Successful participants were more likely to be compliant and to experience fewer adverse events (P≤0.001). CONCLUSIONS: Our study reinforced the belief that the majority of participants with COPD benefit from PR. Few baseline characteristics were predictive of success. Subjectively measured improvement occurred more frequently than objectively measured improvement and was greatest in those with the poorest baseline values.
Authors: François Maltais; Jean Bourbeau; Stan Shapiro; Yves Lacasse; Hélène Perrault; Marc Baltzan; Paul Hernandez; Michel Rouleau; Marcel Julien; Simon Parenteau; Bruno Paradis; Robert D Levy; Pat Camp; Richard Lecours; Richard Audet; Brian Hutton; John R Penrod; Danielle Picard; Sarah Bernard Journal: Ann Intern Med Date: 2008-12-16 Impact factor: 25.391
Authors: Ramsey Sabit; Timothy L Griffiths; Alan J Watkins; Wendy Evans; Charlotte E Bolton; Dennis J Shale; Keir E Lewis Journal: Respir Med Date: 2008-03-11 Impact factor: 3.415
Authors: Praful Schroff; Jason Hitchcock; Christopher Schumann; J Michael Wells; Mark T Dransfield; Surya P Bhatt Journal: Ann Am Thorac Soc Date: 2017-01
Authors: Linzy Houchen-Wolloff; Johanna Ea Williams; Ruth H Green; Gerrit Woltmann; Michael C Steiner; Louise Sewell; Michael Dl Morgan; Sally J Singh Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-12-20
Authors: Lucy L Marlow; Olivia K Faull; Sarah L Finnegan; Kyle T S Pattinson Journal: Curr Opin Support Palliat Care Date: 2019-09 Impact factor: 2.302
Authors: Sara Souto-Miranda; Maria A Mendes; João Cravo; Lília Andrade; Martijn A Spruit; Alda Marques Journal: J Clin Med Date: 2022-01-20 Impact factor: 4.241
Authors: Pierachille Santus; Linda Bassi; Dejan Radovanovic; Andrea Airoldi; Rita Raccanelli; Francesco Triscari; Francesca Giovannelli; Antonio Spanevello Journal: Pulm Med Date: 2013-01-09
Authors: Miek Hornikx; Hans Van Remoortel; Heleen Demeyer; Carlos Augusto Marcal Camillo; Marc Decramer; Wim Janssens; Thierry Troosters Journal: Biomed Res Int Date: 2013-12-26 Impact factor: 3.411
Authors: Frances Early; Jane S Young; Elizabeth Robinshaw; Emma Z Mi; Ella Z Mi; Jonathan P Fuld Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-10-09